| TITRE |
Registre de la Leucémie Myéloïde Chronique (LMC) du GQR-LMC |
| PROTOCOLE ID |
MP-HMR-09-001 |
| CLINICAL TRIAL.gov ID |
|
| TYPE(S) DE CANCER |
Leucémie myéloïde chronique (LMC) |
| PHASE |
Autres |
| TYPE D'ÉTUDE |
|
| INSTITUTION |
CISSS DE LAVAL
1755 boul. René-Laennec
(450) 668-1010
|
| VILLE |
Laval
|
| INVESTIGATEUR(RICE) PRINCIPAL(E) |
Danielle Talbot
|
| COORDONATEUR(RICE) |
Solange Tremblay
stremblay.csssl@ssss.gouv.qc.ca
450-668-1010 poste 23603
|
| STATUT |
Actif en recrutement
|
| CRITÈRES D'ÉLIGIBILITÉ |
(EN)
All patients in Canada who meet the following inclusion criteria may be enrolled in the CML
Registry:
-
have a clinical diagnosis of CML;
-
are 18 years of age or older;
-
are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
|
| CRITÈRES D'EXCLUSION |
(EN)
Patients who meet any of the following criteria will be excluded from participation:
-
unwilling or unable to give written, informed consent;
-
under 18 years of age;
-
life expectancy of 3 months for a condition not related to CML
|
